Malvern, PA, November 13, 2014 — Jim Murphy has joined VenatoRx as Chief Financial Officer. Jim has over 25 years’ experience as a senior financial executive in public and privately held companies in the life sciences and the media and technology industries. He has served as the Chief Financial Officer for three publicly held firms as well as a member of the Board of Directors of Biomimetic Therapeutics where he was the Chair of the Audit Committee. Jim has substantial fund raising experience and has helped to raise over $1.5 billion in financing for the companies he has served. Jim also has extensive merger and acquisition experience having led or participated in the purchase and sale of over 20 companies including both public and privately-held companies. Jim has worked with a number of venture capital firms including Canaan Partners, TL Ventures and Burrill and Company. Jim holds a Bachelor of Science in Accounting with Honors from Villanova University and is a Certified Public Accountant.
Tuesday, October 15 - Wednesday, October 16